Tempei Miyaji

1.8k total citations · 1 hit paper
57 papers, 1.0k citations indexed

About

Tempei Miyaji is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tempei Miyaji has authored 57 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Public Health, Environmental and Occupational Health and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tempei Miyaji's work include Palliative Care and End-of-Life Issues (14 papers), Cancer survivorship and care (11 papers) and Cancer Treatment and Pharmacology (8 papers). Tempei Miyaji is often cited by papers focused on Palliative Care and End-of-Life Issues (14 papers), Cancer survivorship and care (11 papers) and Cancer Treatment and Pharmacology (8 papers). Tempei Miyaji collaborates with scholars based in Japan, United States and United Kingdom. Tempei Miyaji's co-authors include Takuhiro Yamaguchi, Takashi Kawaguchi, Satoru Iwase, Ethan Basch, Hiroki Odagiri, Atsushi Nashimoto, Yasuhiro Kodera, Yoshiyuki Fujiwara, Haruhiko Imamoto and Hiroto Miwa and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Tempei Miyaji

50 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial

2018 250 citations Takuhiro Yamaguchi, Tempei Miyaji et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tempei Miyaji Japan	15	370	350	275	97	96	57	1.0k
Jeong-Soo Im South Korea	10	294 0.8×	391 1.1×	184 0.7×	86 0.9×	29 0.3×	19	988
Takashi Mizutani Japan	20	357 1.0×	281 0.8×	442 1.6×	75 0.8×	73 0.8×	85	1.4k
Jens Hillingsø Denmark	19	178 0.5×	344 1.0×	725 2.6×	96 1.0×	103 1.1×	90	1.3k
Sally W. Wade United States	20	279 0.8×	459 1.3×	255 0.9×	50 0.5×	46 0.5×	65	1.3k
Seri Hong South Korea	19	434 1.2×	549 1.6×	275 1.0×	117 1.2×	34 0.4×	47	1.5k
Clare Shaw United Kingdom	19	156 0.4×	509 1.5×	367 1.3×	97 1.0×	140 1.5×	58	1.1k
Paul Celano United States	15	233 0.6×	194 0.6×	183 0.7×	113 1.2×	30 0.3×	24	1.2k
Adriaan C.I.T.L. Tan Netherlands	19	228 0.6×	131 0.4×	429 1.6×	54 0.6×	111 1.2×	60	1.1k
Savita Verma India	20	238 0.6×	443 1.3×	218 0.8×	81 0.8×	14 0.1×	74	1.3k
George Ramsay United Kingdom	17	312 0.8×	345 1.0×	613 2.2×	63 0.6×	29 0.3×	73	1.3k

Countries citing papers authored by Tempei Miyaji

Since Specialization

Citations

This map shows the geographic impact of Tempei Miyaji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tempei Miyaji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tempei Miyaji more than expected).

Fields of papers citing papers by Tempei Miyaji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tempei Miyaji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tempei Miyaji. The network helps show where Tempei Miyaji may publish in the future.

Co-authorship network of co-authors of Tempei Miyaji

This figure shows the co-authorship network connecting the top 25 collaborators of Tempei Miyaji. A scholar is included among the top collaborators of Tempei Miyaji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tempei Miyaji. Tempei Miyaji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoshino, Eri, Mariko Naito, Yoshimi Suzukamo, et al.. (2024). How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance. BMC Health Services Research. 24(1). 334–334. 2 indexed citations

Matsumoto, Yoshihisa, Shigeki Umemura, Daisuke Fujisawa, et al.. (2024). Nurse‐Led Screening‐Triggered Early Specialized Palliative Care Program for Patients With Advanced Lung Cancer: A Multicenter Randomized Controlled Trial. Cancer Medicine. 13(22). e70325–e70325. 1 indexed citations

Matsuoka, Ayumu, Maiko Fujimori, Atsuo Takashima, et al.. (2024). Geriatric assessment and management with question prompt list using a web-based application for elderly patients with cancer to communicate aging-related concerns: A randomized clinical trial (J-SUPPORT 2101 study).. Journal of Clinical Oncology. 42(16_suppl). 1511–1511. 1 indexed citations

Yamaguchi, Takuhiro, et al.. (2024). The development and analysis of a Japanese modern comprehensive clinical data management training program. Heliyon. 10(6). e27846–e27846.

Kawaguchi, Takashi, Kanako Azuma, Tatsuya Hayama, et al.. (2023). Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study. BMJ Open. 13(11). e073724–e073724.

Matsuoka, Ayumu, Maiko Fujimori, Narikazu Boku, et al.. (2022). Geriatric assessment and management with question prompt list using a web-based application for elderly patients with cancer (MAPLE) to communicate ageing-related concerns: J-SUPPORT 2101 study protocol for a multicentre, parallel group, randomised controlled trial. BMJ Open. 12(9). e063445–e063445. 2 indexed citations

Fujiwara, Masaki, Yuto Yamada, Taichi Shimazu, et al.. (2021). Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial. Acta Psychiatrica Scandinavica. 144(4). 318–328. 16 indexed citations

Mizukami, Takuro, Tempei Miyaji, Yukiya Narita, et al.. (2021). An Observational Study on Nutrition Status in Gastric Cancer Patients Receiving Ramucirumab Plus Taxane: BALAST Study. Future Oncology. 17(19). 2431–2438. 2 indexed citations

Shimomura, Kyoichi, Hitoshi Arioka, Hirotoshi Iihara, et al.. (2021). LBA63 Placebo-controlled, double-blinded phase Ⅲ study comparing dexamethasone on day 1 with dexamethasone on days 1 to 4, with combined neurokinin-1 receptor antagonist, palonosetron, and olanzapine in patients receiving cisplatin-containing highly emetogenic chemotherapy: SPARED trial. Annals of Oncology. 32. S1339–S1340. 2 indexed citations

10.

Izawa, Naoki, Takashi Kawaguchi, Tempei Miyaji, et al.. (2020). Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. BMJ Open. 10(12). e041737–e041737. 1 indexed citations

11.

Zenda, Sadamoto, Atsuo Takashima, Yusuke Takagi, et al.. (2020). Hydrocolloid dressing as a prophylactic use for hand–foot skin reaction induced by multitargeted kinase inhibitors: protocol of a phase 3 randomised self-controlled study. BMJ Open. 10(10). e038276–e038276. 2 indexed citations

12.

Fujisawa, Daisuke, Shigeki Umemura, Eriko Satomi, et al.. (2020). Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial. BMJ Open. 10(11). e037759–e037759. 3 indexed citations

13.

Miyaji, Tempei, Takashi Kawaguchi, Kanako Azuma, et al.. (2020). Patient-generated health data collection using a wearable activity tracker in cancer patients—a feasibility study. Supportive Care in Cancer. 28(12). 5953–5961. 25 indexed citations

14.

Fujiwara, Masaki, Masatoshi Inagaki, Taichi Shimazu, et al.. (2019). A randomised controlled trial of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia in psychiatric outpatient clinics: study protocol for the J-SUPPORT 1901 (ACCESS) study. BMJ Open. 9(11). e032955–e032955. 6 indexed citations

15.

Akechi, Tatsuo, Takuhiro Yamaguchi, Megumi Uchida, et al.. (2018). Smartphone problem-solving and behavioural activation therapy to reduce fear of recurrence among patients with breast cancer (SMartphone Intervention to LEssen fear of cancer recurrence: SMILE project): protocol for a randomised controlled trial. BMJ Open. 8(11). e024794–e024794. 18 indexed citations

16.

Matsuoka, Hiromichi, Hiroto Ishiki, Satoru Iwase, et al.. (2017). Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study. BMJ Open. 7(8). e017280–e017280. 7 indexed citations

17.

Iwase, Satoru, Takashi Kawaguchi, Akihiro Tokoro, et al.. (2015). Assessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09). PLoS ONE. 10(8). e0134022–e0134022. 38 indexed citations

18.

Hangai, Sho, Satoru Iwase, Takashi Kawaguchi, et al.. (2013). Effect of Active Hexose-Correlated Compound in Women Receiving Adjuvant Chemotherapy for Breast Cancer: A Retrospective Study. The Journal of Alternative and Complementary Medicine. 19(11). 905–910. 15 indexed citations

19.

Iwase, Satoru, Takuhiro Yamaguchi, Tempei Miyaji, et al.. (2012). The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients’ symptoms in Japan: a national cross-sectional survey. BMC Complementary and Alternative Medicine. 12(1). 222–222. 26 indexed citations

20.

Kuwahara, Masayoshi, Tempei Miyaji, Hirokazu Tsubone, & Maki Kuwahara. (2000). Angiotensin II type 1 receptor-mediated increase in cytosolic Ca2+ and proliferation in mesothelial cells. European Journal of Pharmacology. 388(1). 21–27. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact